CompoAtlas

克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品

克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品 : Product registered in Taiwan. This registration does not constitute authorisation for sale in France or the European Union. It does not demonstrate the safety or efficacy of the product.

TFDA, Taiwan tablets, capsules and medical nutrition registers, retrieved 27 October 2026.

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Registration number
1106605835
Chinese name
克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品
English name
CROESUS PTGC UC-Ⅱ NO.667 EX SOFTGEL
Type
Imported tablets and capsules
Published status
Status not provided in this export; the validity date is shown separately
Licence holder
雄美有限公司
Registration date
2021-07-07
Published validity end
2026-07-07

The foreign register category does not determine the regulatory category of the product in France.

French and European references for recognised ingredients

No point flagged by the rules applied to recognised ingredients.

Unidentified ingredients are not assessed. The absence of a signal does not establish product compliance.

Published composition

Published ingredientPublished text and quantityIdentified nutrient or substance
MSM (METHYLSULFONYL METHANE)MSM (METHYLSULFONYL METHANE)Not identified
GLUCOSAMINE HCLGLUCOSAMINE HCLNot identified
SHEA BUTTER FRUITSHEA BUTTER FRUITNot identified
SHARK CARTILAGE POWDERSHARK CARTILAGE POWDERNot identified
CHICKEN COLLAGENCHICKEN COLLAGENCollagène de poulet
CALCIUM AMINO ACID CHELATECALCIUM AMINO ACID CHELATECalcium
PILOSE ANTLERPILOSE ANTLERNot identified
TURTLE POWDERTURTLE POWDERNot identified
YUCCA BREVIFOLIA ENGELMAN ROOT EXTRACTYUCCA BREVIFOLIA ENGELMAN ROOT EXTRACTNot identified
CAT'S CLAW ROOT EXTRACTCAT'S CLAW ROOT EXTRACTNot identified
BROMELAINBROMELAINNot identified
SALMON NASAL CARTILAGESALMON NASAL CARTILAGENot identified
TURMERIC ROOT EXTRACTTURMERIC ROOT EXTRACTNot identified
DL-ALPHA TOCOPHERYL ACETATEDL-ALPHA TOCOPHERYL ACETATEVitamine E
THIAMINE MONONITRATETHIAMINE MONONITRATEVitamine B1 (thiamine)
RIBOFLAVINRIBOFLAVINVitamine B2 (riboflavine)
CYANOCOBALAMINCYANOCOBALAMINVitamine B12
VITAMIN D3 (CHOLECALCIFEROL)VITAMIN D3 (CHOLECALCIFEROL)Vitamine D
GELATINGELATINNot identified
GLYCEROLGLYCEROLGlycérol
BEESWAXBEESWAXNot identified
WATERWATERNot identified
SUNSET YELLOW FCFSUNSET YELLOW FCFNot identified
SORBIC ACIDSORBIC ACIDNot identified

The imported data provide no usable daily dosage. No daily dose is estimated and no comparison with dose limits is performed. A published quantity may refer to a preparation or an unspecified unit. Chinese names are retained without translation.

Original register data

View published fields and their variants
Product name
克里薩斯 PTGC UC-Ⅱ 伊霸 667 EX 軟膠囊食品
Active ingredients
MSM (METHYLSULFONYL METHANE);;GLUCOSAMINE HCL;;SHEA BUTTER FRUIT;;SHARK CARTILAGE POWDER;;CHICKEN COLLAGEN;;CALCIUM AMINO ACID CHELATE;;PILOSE ANTLER;;TURTLE POWDER;;YUCCA BREVIFOLIA ENGELMAN ROOT EXTRACT;;CAT'S CLAW ROOT EXTRACT;;BROMELAIN;;SALMON NASAL CARTILAGE;;TURMERIC ROOT EXTRACT;;DL-ALPHA TOCOPHERYL ACETATE;;THIAMINE MONONITRATE;;RIBOFLAVIN;;CYANOCOBALAMIN;;VITAMIN D3 (CHOLECALCIFEROL);;GELATIN;;GLYCEROL;;BEESWAX;;WATER;;SUNSET YELLOW FCF;;SORBIC ACID;;
Valid until
1150707
Registration number
1106605835
Licence holder
雄美有限公司
Registration date
1100707
Published reference
DHC0B066058357
Published English name
CROESUS PTGC UC-Ⅱ NO.667 EX SOFTGEL

Official source

View the official register, number 1106605835

Taiwan Food and Drug Administration (TFDA), Open Government Data License, version 1.0

Open Government Data License, version 1.0

Official warnings (Health Canada)

Health Canada publishes warnings on these ingredients:

  • VITAMIN D3 (CHOLECALCIFEROL)
    Read the warning, when it applies and the studies cited

    VITAMIN D (>1,000 - 2,500 IU)

    Route of administration: Oral

    Cautions and warnings

    Condition of application: All products except products containing zinc sourced from picolinate requiring a contraindication.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are pregnant or breastfeeding.

    Condition of application: All products.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you have kidney disorders (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking other supplements or products containing vitamin D or vitamin D analogues.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking any medications including antacids, anticonvulsants, digoxin, cholestyramine, colestipol, mineral oil, steroids, statins or thiazide diuretics (NNHPD 2021; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use to determine if you would benefit from additional vitamin D as 15-20 mcg (600-800 IU) of vitamin D per day is an adequate quantity for most individuals.

    Applies to products containing vitamin K2.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are taking blood thinners (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing 25-34 mg of zinc per day for adults 18 years or 31-50 mg of zinc per day for adults 19 years and older.

    Ask a health care practitioner/health care provider/health care professional/doctor/physician before use if you are unsure whether you are taking enough copper as zinc supplementation can cause a copper deficiency (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Contraindications

    Condition of application: All products.

    Do not use if you have hypercalcemia and/or hypercalciuria (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products containing zinc sourced from picolinate.

    Do not use if you are pregnant or breastfeeding (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Known adverse reactions

    Condition of application: All products.

    Stop use and ask a health care practitioner/health care provider/health care professional/doctor/physician if the following early symptoms of hypercalcemia occur: weakness, fatigue, drowsiness, headache, lack of appetite, dry mouth, metallic taste, nausea, vomiting, vertigo, ringing in the ears, lack of coordination and muscle weakness or if you develop any other symptom (NIH 2024; BfR 2020).

    2 studies cited in the text have no matching reference in the monograph (see the anomalies listed on the sources page).

    Applies to products providing more than 350 mg of magnesium per day.

    When using this product you may experience diarrhea (NNHPD 2026).

    1 study cited in the text has no matching reference in the monograph (see the anomalies listed on the sources page).

    Health Canada monograph dated 26 June 2026

They concern the ingredient, not this product or its dose. They do not replace medical advice.

The evidence date of this ingredient list is unknown.

Has the product changed? Photograph the packaging.

Is something on this product wrong or out of date, whether you are a reader or the brand? Write to contact@compoatlas.com: every correction is published in the corrections log.

Enter to analyse, Shift+Enter for a new line